TREVISAN, Elisa
TREVISAN, Elisa
A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme
2015-01-01 Vidone, Michele; Clima, Rosanna; Santorsola, Mariangela; Calabrese, Claudia; Girolimetti, Giulia; Kurelac, Ivana; Amato, Laura Benedetta; Iommarini, Luisa; Trevisan, Elisa; Leone, Marco; Soffietti, Riccardo; Morra, Isabella; Faccani, Giuliano; Attimonelli, Marcella; Porcelli, Anna Maria; Gasparre, Giuseppe
Anti-Angiogenic Approaches to Malignant Gliomas
2012-01-01 Riccardo Soffietti;Elisa Trevisan;Luca Bertero;Chiara Bosa;Roberta Ruda
Antiangiogenic therapy of brain tumors: The role of bevacizumab
2014-01-01 Trevisan, Elisa; Bertero, Luca; Bosa, Chiara; Magistrello, Michela; Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
2014-01-01 Soffietti R; Trevisan E; Bertero L; Cassoni P; Morra I; Fabrini MG; Pasqualetti F; Lolli I; Castiglione A; Ciccone G; Rudà R
Chemotherapy
2007-01-01 Soffietti R; Rudà R.; Leoncini B.; Laguzzi E.; Trevisan E.
Efficacy of topiramate in patients with gliomas
2007-01-01 R. Rudà; E. Laguzzi; E. Trevisan; B. Leoncini; D. Guarneri; R. Soffietti
Gliomas: methylation status of MGMT gene monitoring in plasma DNA of patients receiving chemotherapy with alkylating agents
2013-01-01 Valentina, Fiano; Morena, Trevisan; Carlotta, Sacerdote; Anna, Castiglione; Elisa, Trevisan; Rebecca, Senetta; Anna Gillio Tos, ; Laura De Marco, ; Paola, Cassoni; Riccardo Soffietti And Franco Merletti,
Is there a Role for Bevacizumab in Non-Glial Tumors?
2015-01-01 Trevisan, Elisa; Bertero, Luca; Magistrello, Michela; Ruda, Roberta; Soffietti, Riccardo
Neoplasie del sistema nervoso centrale
2013-01-01 Riccardo Soffietti; Roberta Rudà; Luca Bertero; Elisa Trevisan; Chiara Bosa; Isabella Morra
Neoplastic meningitis: Clinico-diagnostic aspects [Meningite neoplastica: Aspetti clinico-diagnostici]
2006-01-01 Soffietti R; Rudà R; Trevisan E
Neuro-Oncologic Emergencies
2005-01-01 R. RUDA'; E. LAGUZZI; E. TREVISAN; R. SOFFIETTI
Neurologic complications of chemotherapy and other newer and experimental approaches
2014-01-01 Soffietti, Riccardo; Trevisan, Elisa; Rudà, Roberta
Safety of bevacizumab in patients with malignant gliomas: A systematic review
2014-01-01 Simonetti, G.*; Trevisan, E.; Silvani, A.; Gaviani, P.; Botturi, A.; Lamperti, E.; Beecher, D.; Bertero, L.; Bosa, C.; Salmaggi, A.
Salvage therapy with bevacizumab and fotemustine in recurrent high grade gliomas
2009-01-01 E.Trevisan; E. Picco; R. Ruda; S.G. Crasto; M.G. Fabrini; V. Scotti; M. Caroli; I. Lolli; D. Guarneri; R. Soffietti
Second-line PCV in recurrent or progressive glioblastomas: A phase II study
2006-01-01 Nobile M; Laguzzi E; Rudà R; Trevisan E; Guarneri D; Soffietti R
Temozolomide in rare brain tumors of the adult: a prospective study.
2005-01-01 R. Soffietti; A. Costanza; E. Laguzzi; E. Trevisan; R. Ruda
What have we learned from trials on antiangiogenic agents in glioblastoma?
2014-01-01 Soffietti, Riccardo; Trevisan, Elisa; Rudà, Roberta
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme | 2015 | Vidone, Michele; Clima, Rosanna; Santorsola, Mariangela; Calabrese, Claudia; Girolimetti, Giulia; Kurelac, Ivana; Amato, Laura Benedetta; Iommarini, Luisa; Trevisan, Elisa; Leone, Marco; Soffietti, Riccardo; Morra, Isabella; Faccani, Giuliano; Attimonelli, Marcella; Porcelli, Anna Maria; Gasparre, Giuseppe | |
| Anti-Angiogenic Approaches to Malignant Gliomas | 2012 | Riccardo Soffietti;Elisa Trevisan;Luca Bertero;Chiara Bosa;Roberta Ruda | |
| Antiangiogenic therapy of brain tumors: The role of bevacizumab | 2014 | Trevisan, Elisa; Bertero, Luca; Bosa, Chiara; Magistrello, Michela; Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo | |
| Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology) | 2014 | Soffietti R; Trevisan E; Bertero L; Cassoni P; Morra I; Fabrini MG; Pasqualetti F; Lolli I; Castiglione A; Ciccone G; Rudà R | |
| Chemotherapy | 2007 | Soffietti R; Rudà R.; Leoncini B.; Laguzzi E.; Trevisan E. | |
| Efficacy of topiramate in patients with gliomas | 2007 | R. Rudà; E. Laguzzi; E. Trevisan; B. Leoncini; D. Guarneri; R. Soffietti | |
| Gliomas: methylation status of MGMT gene monitoring in plasma DNA of patients receiving chemotherapy with alkylating agents | 2013 | Valentina, Fiano; Morena, Trevisan; Carlotta, Sacerdote; Anna, Castiglione; Elisa, Trevisan; Rebecca, Senetta; Anna Gillio Tos, ; Laura De Marco, ; Paola, Cassoni; Riccardo Soffietti And Franco Merletti, | |
| Is there a Role for Bevacizumab in Non-Glial Tumors? | 2015 | Trevisan, Elisa; Bertero, Luca; Magistrello, Michela; Ruda, Roberta; Soffietti, Riccardo | |
| Neoplasie del sistema nervoso centrale | 2013 | Riccardo Soffietti; Roberta Rudà; Luca Bertero; Elisa Trevisan; Chiara Bosa; Isabella Morra | |
| Neoplastic meningitis: Clinico-diagnostic aspects [Meningite neoplastica: Aspetti clinico-diagnostici] | 2006 | Soffietti R; Rudà R; Trevisan E | |
| Neuro-Oncologic Emergencies | 2005 | R. RUDA'; E. LAGUZZI; E. TREVISAN; R. SOFFIETTI | |
| Neurologic complications of chemotherapy and other newer and experimental approaches | 2014 | Soffietti, Riccardo; Trevisan, Elisa; Rudà, Roberta | |
| Safety of bevacizumab in patients with malignant gliomas: A systematic review | 2014 | Simonetti, G.*; Trevisan, E.; Silvani, A.; Gaviani, P.; Botturi, A.; Lamperti, E.; Beecher, D.; Bertero, L.; Bosa, C.; Salmaggi, A. | |
| Salvage therapy with bevacizumab and fotemustine in recurrent high grade gliomas | 2009 | E.Trevisan; E. Picco; R. Ruda; S.G. Crasto; M.G. Fabrini; V. Scotti; M. Caroli; I. Lolli; D. Guarneri; R. Soffietti | |
| Second-line PCV in recurrent or progressive glioblastomas: A phase II study | 2006 | Nobile M; Laguzzi E; Rudà R; Trevisan E; Guarneri D; Soffietti R | |
| Temozolomide in rare brain tumors of the adult: a prospective study. | 2005 | R. Soffietti; A. Costanza; E. Laguzzi; E. Trevisan; R. Ruda | |
| What have we learned from trials on antiangiogenic agents in glioblastoma? | 2014 | Soffietti, Riccardo; Trevisan, Elisa; Rudà, Roberta |